Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
3,06 USD | -6,13% |
|
-16,85% | +84,34% |
27/06 | ADC Therapeutics entrerà a far parte dell'Indice Russell 3000 | MT |
30/05 | ADC THERAPEUTICS SA : Cantor Fitzgerald mantiene la raccomandazione Buy | ZM |
Attività
Numero di dipendenti: 274
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Antibody Drug Conjugates
100,0
%
| 210 | 100,0 % | 70 | 100,0 % | -66,86% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Ameet Mallik
CEO | Chief Executive Officer | 51 | 09/05/22 |
Jose Carmona
DFI | Director of Finance/CFO | 51 | 19/12/22 |
Mohamed Zaki
CTO | Chief Tech/Sci/R&D Officer | 59 | 03/01/23 |
Chief Tech/Sci/R&D Officer | 55 | 01/08/12 | |
Chief Tech/Sci/R&D Officer | 69 | 01/11/22 | |
Corporate Officer/Principal | 51 | 17/11/22 | |
Kimberly Pope
HRO | Human Resources Officer | 57 | 17/08/20 |
Peter J. Graham
LAW | General Counsel | 57 | 01/11/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Peter Hug
BRD | Director/Board Member | 65 | 01/06/19 |
Ron Squarer
CHM | Chairman | 57 | 01/04/20 |
Jean Bizzari
BRD | Director/Board Member | 69 | 01/07/22 |
Ameet Mallik
CEO | Chief Executive Officer | 51 | 09/05/22 |
Victor Sandor
BRD | Director/Board Member | 57 | 27/04/20 |
Robert Azelby
BRD | Director/Board Member | 56 | 14/06/23 |
Thomas Pfisterer
BRD | Director/Board Member | 42 | 01/10/16 |
Tyrell J. Rivers
BRD | Director/Board Member | 51 | 01/06/18 |
Viviane Monges
BRD | Director/Board Member | 60 | 11/06/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 102 453 858 | 75 901 578 ( 74,08 %) | 6 264 720 ( 6,115 %) | 74,08 % |
Coordinate società
![Indirizzo ADC Therapeutics SA(ADCT)](https://cdn.zonebourse.com/static/address/66481721.png)
Settore
Vendite per regione
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+84,34% | 294 Mln | |
+18,43% | 124 Mrd | |
+19,81% | 114 Mrd | |
-23,74% | 19,42 Mrd | |
-18,05% | 16,2 Mrd | |
-19,97% | 15,31 Mrd | |
-49,33% | 14,19 Mrd | |
+57,08% | 14,32 Mrd | |
+7,95% | 14,31 Mrd | |
+126,04% | 11,29 Mrd |
- Borsa valori
- Azioni
- Azione ADCT
- Società ADC Therapeutics SA